Kitov Pharma Ltd. registered direct offering of 3,260,000 ADS to U.S. institutional investors

Attorneys Perry Wildes, Oded Bejarano and intern Avshalom Lavski represented Kitov Pharma Ltd. in connection with a registered direct offering of 3,260,000 American Depositary Shares (ADS) to U.S. institutional investors. Kitov Pharma also issued unregistered warrants to purchase up to 1,630,000 ADSs. Gross proceeds from the offering were $8.15 million.

CNBC – 01/06/2018

June 5, 2018

Perry Wildes

Phone +972-3-6074520

Download vCard

Oded Bejarano

Phone +972-3-6074479

Download vCard